One month dosing of atomoxetine plus oxybutynin in obstructive sleep apnea: a randomized, placebo-controlled trial
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
A Aishah, KA Loffler, B Toson, S Mukherjee… - 2022 - digital.library.adelaide.edu.au
RATIONALE: The combination of noradrenergic and anti-muscarinic agents has recently
been shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) …
been shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) …
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea A Randomized, Placebo-controlled Trial.
A Aishah, KA Loffler, B Toson… - Annals of the …, 2023 - search.ebscohost.com
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been
shown to improve upperairway function and reduce obstructive sleep apnea (OSA) severity …
shown to improve upperairway function and reduce obstructive sleep apnea (OSA) severity …
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial
A Aishah, KA Loffler, B Toson, S Mukherjee, RJ Adams… - 2023 - pubmed.ncbi.nlm.nih.gov
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
A Aishah, KA Loffler, B Toson, S Mukherjee… - Annals of the …, 2022 - europepmc.org
The combination of noradrenergic and anti-muscarinic agents has recently been shown to
improve upper-airway function and reduce obstructive sleep apnea (OSA) severity in short …
improve upper-airway function and reduce obstructive sleep apnea (OSA) severity in short …
One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial
A Aishah, KA Loffler, B Toson… - Annals of the …, 2023 - researchnow.flinders.edu.au
Rationale: The combination of noradrenergic and antimuscarinic agents has recently been
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …
shown to improve upper-airway function and reduce obstructive sleep apnea (OSA) severity …